A Oksa

Summary

Affiliation: Slovak Medical University
Country: Slovakia

Publications

  1. ncbi request reprint Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers?
    A Oksa
    Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia
    Bratisl Lek Listy 107:314-9. 2006
  2. doi request reprint Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease
    Adrian Oksa
    Department of Clinical and Experimental Pharmacotherapy, Slovak Health University, Bratislava, Slovakia
    Kidney Blood Press Res 31:322-9. 2008
  3. ncbi request reprint Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3
    K Stefikova
    Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia
    Physiol Res 60:149-55. 2011
  4. ncbi request reprint [Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy]
    A Oksa
    Ustav preventívnej a klinickej medicíny, Bratislava, Slovenska republika
    Vnitr Lek 49:217-21. 2003

Detail Information

Publications4

  1. ncbi request reprint Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers?
    A Oksa
    Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia
    Bratisl Lek Listy 107:314-9. 2006
    ..Some of these novel risk factors, particularly markers of inflammation, endothelial function, hemocoagulation and fibrinolysis are discussed, and their significance in the prediction of CV and renal outcome examined (Tab. 1, Ref 57)...
  2. doi request reprint Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease
    Adrian Oksa
    Department of Clinical and Experimental Pharmacotherapy, Slovak Health University, Bratislava, Slovakia
    Kidney Blood Press Res 31:322-9. 2008
    ..We assessed the effects of the 12-month vitamin D(3) treatment on mineral metabolism and calciotropic hormones in patients with CKD stages 2-4...
  3. ncbi request reprint Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3
    K Stefikova
    Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia
    Physiol Res 60:149-55. 2011
    ..Our results support the increasing evidence that vitamin D deficiency may be one of the factors participating in the development of insulin resistance already in the early stages of chronic kidney disease...
  4. ncbi request reprint [Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy]
    A Oksa
    Ustav preventívnej a klinickej medicíny, Bratislava, Slovenska republika
    Vnitr Lek 49:217-21. 2003
    ..The long-term effect of such treatment on the progression of atherosclerotic nephropathy is now being evaluated in randomized trials...